| 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical … DK Arnett, RS Blumenthal, MA Albert, AB Buroker, ZD Goldberger, ... Journal of the American College of cardiology 74 (10), e177-e232, 2019 | 8561* | 2019 |
| Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association J Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa, KL Lentine, ... Circulation 139 (16), e840-e878, 2019 | 998 | 2019 |
| Mechanisms of ENaC regulation and clinical implications V Bhalla, KR Hallows Journal of the American Society of Nephrology 19 (10), 1845-1854, 2008 | 362 | 2008 |
| Serum-and glucocorticoid-regulated kinase 1 regulates ubiquitin ligase neural precursor cell-expressed, developmentally down-regulated protein 4-2 by inducing interaction with … V Bhalla, D Daidie, H Li, AC Pao, LP LaGrange, J Wang, A Vandewalle, ... Molecular endocrinology 19 (12), 3073-3084, 2005 | 207 | 2005 |
| American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal syndrome: classification, pathophysiology, diagnosis … J Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa, KL Lentine, ... Circulation 139 (16), e840-e878, 2019 | 206 | 2019 |
| Melamine nephrotoxicity: an emerging epidemic in an era of globalization V Bhalla, PC Grimm, GM Chertow, AC Pao Kidney international 75 (8), 774-779, 2009 | 188 | 2009 |
| AMP-activated kinase inhibits the epithelial Na+ channel through functional regulation of the ubiquitin ligase Nedd4-2 V Bhalla, NM Oyster, AC Fitch, MA Wijngaarden, D Neumann, ... Journal of Biological Chemistry 281 (36), 26159-26169, 2006 | 170 | 2006 |
| Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart Association J Rangaswami, V Bhalla, IH De Boer, A Staruschenko, JA Sharp, ... Circulation 142 (17), e265-e286, 2020 | 158 | 2020 |
| Screening rates for primary aldosteronism in resistant hypertension: a cohort study G Jaffe, Z Gray, G Krishnan, M Stedman, Y Zheng, J Han, GM Chertow, ... Hypertension 75 (3), 650-659, 2020 | 142 | 2020 |
| 2019 AHA/ACC clinical performance and quality measures for adults with high blood pressure: a report of the American College of Cardiology/American Heart Association Task Force … DE Casey, RJ Thomas, V Bhalla, Y Commodore-Mensah, PA Heidenreich, ... Journal of the American College of Cardiology 74 (21), 2661-2706, 2019 | 141 | 2019 |
| SGK1: a rapid aldosterone-induced regulator of renal sodium reabsorption JA McCormick, V Bhalla, AC Pao, D Pearce Physiology 20 (2), 134-139, 2005 | 139 | 2005 |
| Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among US veterans: a retrospective cohort study JB Cohen, DL Cohen, DS Herman, JT Leppert, JB Byrd, V Bhalla Annals of internal medicine 174 (3), 289-297, 2021 | 134 | 2021 |
| Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ V Bhalla, R Soundararajan, AC Pao, H Li, D Pearce American journal of physiology-renal physiology 291 (4), F714-F721, 2006 | 128 | 2006 |
| Sound science before quick judgement regarding RAS blockade in COVID-19 MA Sparks, A South, P Welling, JM Luther, J Cohen, JB Byrd, LM Burrell, ... Clinical Journal of the American Society of Nephrology 15 (5), 714-716, 2020 | 106 | 2020 |
| Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease V Bhalla, B Zhao, KMJ Azar, EJ Wang, S Choi, EC Wong, SP Fortmann, ... Diabetes care 36 (5), 1215-1221, 2013 | 95 | 2013 |
| Recurrent and de novo diabetic nephropathy in renal allografts V Bhalla, CC Nast, N Stollenwerk, S Tran, L Barba, ES Kamil, G Danovitch, ... Transplantation 75 (1), 66-71, 2003 | 85 | 2003 |
| Low-level lead exposure and the prevalence of gout: an observational study E Krishnan, B Lingala, V Bhalla Annals of internal medicine 157 (4), 233-241, 2012 | 76 | 2012 |
| A historical perspective on ACE2 in the COVID-19 era V Bhalla, CA Blish, AM South Journal of Human Hypertension 35 (10), 935-939, 2021 | 72 | 2021 |
| Neural precursor cell-expressed developmentally down-regulated protein 4-2 (Nedd4-2) regulation by 14-3-3 protein binding at canonical serum and glucocorticoid kinase 1 (SGK1 … S Chandran, H Li, W Dong, K Krasinska, C Adams, L Alexandrova, ... Journal of Biological Chemistry 286 (43), 37830-37840, 2011 | 58 | 2011 |
| Phosphopeptide screen uncovers novel phosphorylation sites of Nedd4-2 that potentiate its inhibition of the epithelial Na+ channel KR Hallows, V Bhalla, NM Oyster, MA Wijngaarden, JK Lee, H Li, ... Journal of Biological Chemistry 285 (28), 21671-21678, 2010 | 51 | 2010 |
